JNJ — Johnson & Johnson · P/E 17, rev $94.19B

Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.

Latest reported JNJ revenue for 2025-12-28 was $94.19B. Net income was $26.80B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.

Use this JNJ page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the JNJ quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the JNJ SEC filings page. Lician reads the product cache first so this HTML stays unique to Johnson & Johnson even when a live quote feed is slow.

Johnson & Johnson latest statements (FY2025)

Latest cached year on this hub. Full JNJ income, balance, and cash tables.

  • Revenue$94.19B
  • Net Income$26.80B
  • Total Assets$199.21B
  • Total Debt$0
  • Free Cash Flow$19.70B

JNJ recent filings